CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Citius Pharmaceuticals, Inc. - CTXR CFD

0.3871
1.07%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0044
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024846 %
Charges from full value of position ($-4.72)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024846%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002624 %
Charges from full value of position ($0.50)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002624%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.3913
Open 0.4005
1-Year Change -40.15%
Day's Range 0.3829 - 0.4005
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Oct 8, 2024 0.3871 -0.0067 -1.70% 0.3938 0.4087 0.3827
Oct 7, 2024 0.3913 -0.0324 -7.65% 0.4237 0.4247 0.3856
Oct 4, 2024 0.4327 -0.0160 -3.57% 0.4487 0.4567 0.4262
Oct 3, 2024 0.4393 -0.0114 -2.53% 0.4507 0.4637 0.4301
Oct 2, 2024 0.4645 -0.0142 -2.97% 0.4787 0.4787 0.4287
Oct 1, 2024 0.4640 -0.0347 -6.96% 0.4987 0.4987 0.4362
Sep 30, 2024 0.4974 -0.0122 -2.39% 0.5096 0.5373 0.4887
Sep 27, 2024 0.5204 0.0117 2.30% 0.5087 0.5382 0.4997
Sep 26, 2024 0.5093 0.0044 0.87% 0.5049 0.5125 0.4987
Sep 25, 2024 0.5106 -0.0182 -3.44% 0.5288 0.5340 0.4998
Sep 24, 2024 0.5305 -0.0181 -3.30% 0.5486 0.5486 0.5199
Sep 23, 2024 0.5464 -0.0323 -5.58% 0.5787 0.5987 0.5387
Sep 20, 2024 0.5552 -0.0135 -2.37% 0.5687 0.5687 0.5357
Sep 19, 2024 0.5418 0.0031 0.58% 0.5387 0.5706 0.5187
Sep 18, 2024 0.5103 0.0015 0.29% 0.5088 0.5167 0.4998
Sep 17, 2024 0.5004 -0.0083 -1.63% 0.5087 0.5178 0.4987
Sep 16, 2024 0.4988 -0.0099 -1.95% 0.5087 0.5237 0.4905
Sep 13, 2024 0.5143 -0.0044 -0.85% 0.5187 0.5285 0.5087
Sep 12, 2024 0.5133 -0.0154 -2.91% 0.5287 0.5302 0.5102
Sep 11, 2024 0.5263 -0.0024 -0.45% 0.5287 0.5337 0.4787

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Citius Pharmaceuticals, Inc. Company profile

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution for treating patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering with hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, a engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Industry: Biotechnology & Medical Research (NEC)

11 Commerce Dr Fl 1
CRANFORD
NEW JERSEY 07016-3501
US

News

US Core CPI tipped to remain unchanged in September

US inflation expectations are steady, with core CPI projected to remain at 3.2% for September while headline inflation moderates to its lowest level since February 2021. Despite the US Federal Reserve delivering a 50 basis point interest rate cut in September, stronger-than-expected job market data has raised concerns about sustained economic demand and inflation pressures.

07:10, 9 October 2024

RBNZ expected to deliver “jumbo” rate cut

The Reserve Bank of New Zealand is set to cut interest rates during its upcoming meeting, with expectations of either a 25 or 50 basis point reduction. This move follows a 25 basis point cut in August as the RBNZ responded to the country’s recessionary conditions and inflation concerns.

08:48, 8 October 2024

September Non-Farm Payrolls eases fears of US economic slowdown

Markets are reacting with a US Dollar surge and a potential trend reversal, highlighting the impact of robust economic activity outside of monetary policy influences.

07:44, 8 October 2024

Gold's recent story

Last week, we explored the key price drivers of gold, and how they impacted the price of the precious metal this year and last. Now, we’ll bring these factors to life in a chart, showing you ten instances the gold price responded to critical fundamental events, including central bank policies, global economic data, and geopolitical events.

15:36, 7 October 2024

September US Non-Farm Payrolls Preview

Kyle Rodda, Senior Market Analyst at Capital.com, previews the US Non-Farm Payrolls report for September. The article discusses market expectations of a stable labor market with 150,000 new jobs, an unchanged unemployment rate of 4.2%, and steady annual wage growth at 3.8%. It also highlights potential rate cuts by the Federal Reserve, revisions to past payroll data, and the reaction of various markets such as the US Dollar, S&P 500, and gold.

07:59, 2 October 2024

Market of the Month - Gold, an overview

In 2024, gold has been on an upward trajectory, hitting high after high as global markets face ongoing challenges. This precious metal, long seen as a safe haven, has been proving its worth, drawing attention from traders around the world as its bullish surge continues.

06:00, 30 September 2024

RBA Preview: Rates to remain unchanged with inflation-fighting still the focus

RBA Governor Michelle Bullock emphasizes inflation challenges for Australia's economy, citing supply shocks and demand-supply imbalances. Discover insights on CPI trends, interest rates, and the central bank's strategy for managing price pressures in 2024.

12:27, 20 September 2024

People also watch

Gold

2,618.33 Price
0.000% 1D Chg, %
Long position overnight fee -0.0179%
Short position overnight fee 0.0097%
Overnight fee time 21:00 (UTC)
Spread 0.30

US100

20,081.70 Price
-0.070% 1D Chg, %
Long position overnight fee -0.0248%
Short position overnight fee 0.0026%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

0.54 Price
+0.260% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

62,192.45 Price
-0.460% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 650,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading